問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCO-338-087/ GOG-3020/ ENGOT-ov45/NCRI/ATHENA
Active

2019-01-01 - 2030-12-31

Phase III

Recruiting1

Terminated13

ICD-10C56

Malignant neoplasm of ovary

ICD-9620.2

Other and unspecified ovarian cyst

  • Trial Applicant

    CMIC Asia-Pacific

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator

Co-Principal Investigator

  • 周宏學 Division of Obstetrics & Gynecology
  • 周宏學 Division of Obstetrics & Gynecology

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Peng-Hui Wang Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

4 Terminated

Audit

None

Principal Investigator Chien-Hsing Lu Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 余慕賢 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 劉文雄 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 蕭聖謀 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 張志隆 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Lian-Shung Yeh

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 康介乙 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 黃文聰 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 康介乙醫師 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    30 participants

  • Global

    1000 participants